Evidence map›Paper›PMID 30849945›Full record

ArticleBMC cancer2019

Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy.

B M Donida, G Tomasello, M Ghidini, F Buffoli, M Grassi, W Liguigli, G Maglietta, L Pergola, M Ratti, G Sabadini and 3 more

Abstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Updating the Prevalence ofJournal of clinical medicine · 2026
    Article
  2. Article
  3. Paradigm Shift in Gastric Cancer Prevention: Harnessing the Potential ofInternational journal of molecular sciences · 2023
    Article
  4. Evolutionarily-RelatedMicroorganisms · 2020
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

B M DonidaASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy. b.donida@asst-cremona.it.
G TomaselloASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy.
M GhidiniASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy.
F BuffoliASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy.
M GrassiASST of Crema, Largo Ugo Dossena 2, 26013, Crema, CR, Italy.
W LiguigliHospital of Suzzara, Via General Cantore 14/b, 46029, Suzzara, MN, Italy.
G MagliettaUniversity Hospital of Parma, Via Gramsci 14, 43126, Parma, PR, Italy.
L PergolaASST of Crema, Largo Ugo Dossena 2, 26013, Crema, CR, Italy.
M RattiASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy.
G SabadiniIstituto Figlie San Camillo of Cremona, Via Fabio Filzi 56, 26100, Cremona, CR, Italy.
L ToppoCivil Hospital of Voghera, ASST of Pavia, Via Indipendenza 34, 27100, Pavia, PV, Italy.
M UngariASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy.
R PassalacquaASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe gastric cancer incidence rate differs widely across geographical areas. In Italy, in the province of Cremona the incidence is high, compared to the national situation. For this reason a specialized population-based registry was set up.

methodsThe collection encompasses all gastric cancers diagnosed in the three districts of the province since January 1, 2010. The main data sources were the pathological and Hospital Discharge Records and patient clinical charts. Only diagnoses of primary gastric cancer were considered. For each case the following variables were registered: personal data, medical history and symptoms at diagnosis; imaging assessments performed, details on surgery and other treatments received; genetic background and biomolecular characteristics; social and environmental factors.

resultsAs of November 2017, 1087 cases were collected; of which 876, diagnosed up to December 2015, were analyzed. Male/female ratio was 1.4. The European Age-standardized Incidence Rate was 41.4 for males and 28.3 for females as compared to a national average of 33.3 and 17.0 respectively. Median age at diagnosis was 73 for male and 78 for female. Helicobacter Pylori infection was present in fewer than 20% of cases. HER-2 gene was amplified in about 25% of cases. Primary tumour location was the gastro-esophageal junction or cardia in 17.5% in males and 8.3% in females. The majority of cases (58.3%) were diagnosed at an advanced stage and overall only 41.2% underwent surgery. Median overall survival was 14.8 months for men and 18.5 for women. Age standardized 5-year relative survival was 31.4% for men and 40.5% for females. Neoadjuvant treatment was performed in fewer than 10% of patients who underwent surgery, and the rate of postoperative therapy adherence was low. DISCUSSION: This study shows a high gastric cancer incidence in the province of Cremona, with a geographical spread across different districts. Moreover, a high percentage of gastric cancers were detected at an advanced stage of disease and a low rate of 5-year relative survival was registered. Based on these findings, effective preventive interventional health strategies and screening procedures need to be implemented to reduce the impact of this pathology in this geographical area.

Indexed as

AgedAged, 80 and overBiomarkers, TumorFemaleHumansIncidenceItalyKaplan-Meier EstimateMaleMiddle AgedNeoplasm GradingNeoplasm StagingPatient Outcome AssessmentPopulation SurveillancePrognosisRegistriesBiomarkers, TumorGastric cancer clinical characteristicsGastric cancer incidenceGastric cancer pathological characteristicsGastric cancer survivalPopulation-based specialized registry

Identifiers

PMID30849945
PMCPMC6408835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.